Literature DB >> 8686696

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study.

J W Jama1, L J Launer, J C Witteman, J H den Breeijen, M M Breteler, D E Grobbee, A Hofman.   

Abstract

Antioxidants have been implicated in processes related to atherosclerosis, aging, and selective neuronal damage, all of which may ultimately affect cognitive function. In a sample of older persons, the authors examined the cross-sectional relation between cognitive function and dietary intake of beta-carotene and vitamins C and E. The data were derived from 5,182 community participants aged 55-95 years in the population-based Rotterdam Study in the period 1990 to 1993. Dietary intake was estimated from a semi-quantitative food frequency questionnaire and categorized into five levels of intake. Cognitive function was measured with the 30-point Mini-Mental State Examination (MMSE) and characterized as unimpaired (> 25 points) or impaired (< or = 25 points). Logistic regression analysis was used to estimate the odds ratio (OR) and 95% confidence interval (CI) for cognitive impairment. After adjustment for age, education, sex, smoking, total caloric intake, and intake of other antioxidants, a lower intake of beta-carotene was associated with impaired cognitive function (< 0.9 mg vs. > or = 2.1 mg intake, OR = 1.9, 95% CI 1.2-3.1; p for trend < 0.04). There was no association between cognitive function and intake of vitamins C and E. These cross-sectional observations are compatible with the view that beta-carotene-rich foods may protect against cognitive impairment in older people. The finding could also reflect unmeasured confounding, measurement error, or a change in food habits that resulted from rather than preceded the onset of cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686696     DOI: 10.1093/oxfordjournals.aje.a008922

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  57 in total

1.  The case against the gun industry.

Authors:  B J Siebel
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

2.  Adolescent and adult pertussis. A problem and a solution.

Authors:  R Schabas
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

3.  The EUROSTROKE cohorts: a short description and data analytical approach.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; A Trichopoulou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

4.  Counteracting tobacco motor sports sponsorship as a promotional tool: is the tobacco settlement enough?

Authors:  M Siegel
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

5.  Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.

Authors:  S Suissa; P Ernst; A Kezouh
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 6.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Pro12Ala polymorphism in PPAR-gamma2 and dementia in Chinese nonagenarians/centenarians.

Authors:  Ji-Rong Yue; Bi-Rong Dong; Chang-Quan Huang; Zhen-Chan Lu; Hong-Mei Wu; Yan-Ling Zhang
Journal:  Age (Dordr)       Date:  2010-01-27

Review 8.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics.

Authors:  S Melov; S R Doctrow; J A Schneider; J Haberson; M Patel; P E Coskun; K Huffman; D C Wallace; B Malfroy
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 10.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.